These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 18223205

  • 1. Is breast tumor progression really linear?
    Polyak K.
    Clin Cancer Res; 2008 Jan 15; 14(2):339-41. PubMed ID: 18223205
    [No Abstract] [Full Text] [Related]

  • 2. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
    Jing X, Kakudo K, Murakami M, Nakamura Y, Nakamura M, Yokoi T, Yang Q, Oura S, Sakurai T.
    Cancer; 1999 Aug 01; 86(3):439-48. PubMed ID: 10430252
    [Abstract] [Full Text] [Related]

  • 3. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL, Gao P, Wu YG, Jian WC, Hao CY, Li H, Lin XY.
    Arch Med Res; 2007 Nov 01; 38(8):846-52. PubMed ID: 17923265
    [Abstract] [Full Text] [Related]

  • 4. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer.
    Ivkovic-Kapicl T, Knezevic-Usaj S, Djilas-Ivanovic D, Panjkovic M.
    In Vivo; 2007 Nov 01; 21(4):673-8. PubMed ID: 17708365
    [Abstract] [Full Text] [Related]

  • 5. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.
    Hum Pathol; 2009 Sep 01; 40(9):1224-33. PubMed ID: 19439346
    [Abstract] [Full Text] [Related]

  • 6. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP.
    Am J Surg Pathol; 2009 Apr 01; 33(4):496-504. PubMed ID: 19047897
    [Abstract] [Full Text] [Related]

  • 7. A case of intraductal carcinoma with pleomorphic cells.
    Cordoba A, Guerrero-Setas D, Vicente F, Mercado MR, Rodriguez I, Martinez-Peñuela JM.
    Pathol Int; 2012 Jul 01; 62(7):511-2. PubMed ID: 22726073
    [No Abstract] [Full Text] [Related]

  • 8. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
    García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M.
    Cancer Invest; 2006 Mar 01; 24(2):119-25. PubMed ID: 16537179
    [Abstract] [Full Text] [Related]

  • 9. Basal cytokeratin expression in relation to biological factors in breast cancer.
    Kuroda H, Ishida F, Nakai M, Ohnisi K, Itoyama S.
    Hum Pathol; 2008 Dec 01; 39(12):1744-50. PubMed ID: 18755493
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
    Simooka H, Oyama T, Sano T, Horiguchi J, Nakajima T.
    Pathol Int; 2004 Aug 01; 54(8):595-602. PubMed ID: 15260850
    [Abstract] [Full Text] [Related]

  • 11. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
    Kaya H, Bozkurt SU, Erbarut I, Djamgoz MB.
    Pathol Res Pract; 2008 Aug 01; 204(6):367-71. PubMed ID: 18342452
    [Abstract] [Full Text] [Related]

  • 12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 01; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 13. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.
    Yoder BJ, Wilkinson EJ, Massoll NA.
    Breast J; 2007 Jan 01; 13(2):172-9. PubMed ID: 17319859
    [Abstract] [Full Text] [Related]

  • 14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 01; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 15. Characterization of breast lesions with proton MR spectroscopy.
    Yeh ED.
    AJR Am J Roentgenol; 2003 Nov 01; 181(5):1273-4. PubMed ID: 14573419
    [No Abstract] [Full Text] [Related]

  • 16. Expressions of cyclin D1, p53, bcl-2, and bax in infiltrative ductal carcinoma of the breast: correlations with clinicopathologic characteristics.
    Arýkök AT, Onal BU, Han U.
    Breast J; 2006 Nov 01; 12(4):391-2. PubMed ID: 16848860
    [No Abstract] [Full Text] [Related]

  • 17. The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma.
    Kim DJ, Park JY, Lee MH, Sohn YK.
    J Korean Med Sci; 2004 Oct 01; 19(5):698-703. PubMed ID: 15483347
    [Abstract] [Full Text] [Related]

  • 18. Significance of HER2 protein examination in ductal carcinoma in situ.
    Horimoto Y, Tokuda E, Arakawa A, Kosaka T, Saito M, Kasumi F.
    J Surg Res; 2011 May 15; 167(2):e205-10. PubMed ID: 20018297
    [Abstract] [Full Text] [Related]

  • 19. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
    Faratian D, Munro A, Twelves C, Bartlett JM.
    Histopathology; 2009 Jan 15; 54(2):254-7. PubMed ID: 19207951
    [Abstract] [Full Text] [Related]

  • 20. Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations.
    Formantici C, Orlandi R, Ronchini C, Pilotti S, Ranzani GN, Colnaghi MI, Ménard S.
    J Pathol; 1999 Mar 15; 187(4):424-7. PubMed ID: 10398101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.